Source: Anais. Conference titles: Congresso Brasileiro de Microbiologia - CBM. Unidade: FCF
ABNT
RIVERA, Massiel e MONTEIRO, Gisele. A chimeric protein engineered of L-asparaginase and Arginase I for thetreatment of leukemia: production, in silico analysis and enzymatic evaluation. 2023, Anais.. São Paulo: Sociedade Brasileira de Microbiologia - SBM, 2023. Disponível em: https://sbmicrobiologia.org.br/32cbm-anais/resumo.htm. Acesso em: 18 ago. 2024.APA
Rivera, M., & Monteiro, G. (2023). A chimeric protein engineered of L-asparaginase and Arginase I for thetreatment of leukemia: production, in silico analysis and enzymatic evaluation. In Anais. São Paulo: Sociedade Brasileira de Microbiologia - SBM. Recuperado de https://sbmicrobiologia.org.br/32cbm-anais/resumo.htmNLM
Rivera M, Monteiro G. A chimeric protein engineered of L-asparaginase and Arginase I for thetreatment of leukemia: production, in silico analysis and enzymatic evaluation [Internet]. Anais. 2023 ;[citado 2024 ago. 18 ] Available from: https://sbmicrobiologia.org.br/32cbm-anais/resumo.htmVancouver
Rivera M, Monteiro G. A chimeric protein engineered of L-asparaginase and Arginase I for thetreatment of leukemia: production, in silico analysis and enzymatic evaluation [Internet]. Anais. 2023 ;[citado 2024 ago. 18 ] Available from: https://sbmicrobiologia.org.br/32cbm-anais/resumo.htm